MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Zidovudine not adversely affected by short-term exposure to heat and sunlight. Capsules may become discolored or brittle and should be protected from light, heat, and moisture.

Provenance

This compatibility recommendation is derived from Retrovir 100mg capsules (ViiV Healthcare UK Ltd)

Stability Notes

Zidovudine not adversely affected by short-term exposure to heat and sunlight. Capsules may become discolored or brittle and should be protected from light, heat, and moisture.

Provenance

This compatibility recommendation is derived from Retrovir 250mg capsules (ViiV Healthcare UK Ltd)

Stability Notes

Protect from moisture as slightly hygroscopic and slightly soluble in water. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Revatio 20mg tablets (Viatris UK Healthcare Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Revolade 25mg tablets (Novartis Pharmaceuticals UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Revolade 50mg tablets (Novartis Pharmaceuticals UK Ltd).

Stability Notes

There are no stability notes available for this medicine.

Stability Notes

Protect from light and store in airtight containers. Freely soluble in water.

Provenance

This compatibility recommendation is derived from Ribavirin 200mg capsules (Milpharm Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.